Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by aberrant amyloid-β (Aβ) and hyperphosphorylated tau aggregation. We have previously investigated the involvement of SEPTIN family members in AD-related cellular processes and discovered a role for SEPTIN8 in the sorting and acc...

Full description

Bibliographic Details
Main Authors: Mikael Marttinen, Catarina B. Ferreira, Kaisa M. A. Paldanius, Mari Takalo, Teemu Natunen, Petra Mäkinen, Luukas Leppänen, Ville Leinonen, Kenji Tanigaki, Gina Kang, Noboru Hiroi, Hilkka Soininen, Kirsi Rilla, Annakaisa Haapasalo, Mikko Hiltunen
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/11/2482
_version_ 1797547820163530752
author Mikael Marttinen
Catarina B. Ferreira
Kaisa M. A. Paldanius
Mari Takalo
Teemu Natunen
Petra Mäkinen
Luukas Leppänen
Ville Leinonen
Kenji Tanigaki
Gina Kang
Noboru Hiroi
Hilkka Soininen
Kirsi Rilla
Annakaisa Haapasalo
Mikko Hiltunen
author_facet Mikael Marttinen
Catarina B. Ferreira
Kaisa M. A. Paldanius
Mari Takalo
Teemu Natunen
Petra Mäkinen
Luukas Leppänen
Ville Leinonen
Kenji Tanigaki
Gina Kang
Noboru Hiroi
Hilkka Soininen
Kirsi Rilla
Annakaisa Haapasalo
Mikko Hiltunen
author_sort Mikael Marttinen
collection DOAJ
description Alzheimer’s disease (AD) is a neurodegenerative disease characterized by aberrant amyloid-β (Aβ) and hyperphosphorylated tau aggregation. We have previously investigated the involvement of SEPTIN family members in AD-related cellular processes and discovered a role for SEPTIN8 in the sorting and accumulation of β-secretase. Here, we elucidated the potential role of SEPTIN5, an interaction partner of SEPTIN8, in the cellular processes relevant for AD, including amyloid precursor protein (APP) processing and the generation of Aβ. The in vitro and in vivo studies both revealed that the downregulation of SEPTIN5 reduced the levels of APP C-terminal fragments (APP CTFs) and Aβ in neuronal cells and in the cortex of Septin5 knockout mice. Mechanistic elucidation revealed that the downregulation of SEPTIN5 increased the degradation of APP CTFs, without affecting the secretory pathway-related trafficking or the endocytosis of APP. Furthermore, we found that the APP CTFs were degraded, to a large extent, via the autophagosomal pathway and that the downregulation of SEPTIN5 enhanced autophagosomal activity in neuronal cells as indicated by altered levels of key autophagosomal markers. Collectively, our data suggest that the downregulation of SEPTIN5 increases the autophagy-mediated degradation of APP CTFs, leading to reduced levels of Aβ in neuronal cells.
first_indexed 2024-03-10T14:49:43Z
format Article
id doaj.art-5647ef2d3b1d45008a721e15b1ef2b35
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T14:49:43Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-5647ef2d3b1d45008a721e15b1ef2b352023-11-20T21:02:14ZengMDPI AGCells2073-44092020-11-01911248210.3390/cells9112482Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of AβMikael Marttinen0Catarina B. Ferreira1Kaisa M. A. Paldanius2Mari Takalo3Teemu Natunen4Petra Mäkinen5Luukas Leppänen6Ville Leinonen7Kenji Tanigaki8Gina Kang9Noboru Hiroi10Hilkka Soininen11Kirsi Rilla12Annakaisa Haapasalo13Mikko Hiltunen14Institute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandInstituto de Medicina Molecular—João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, PortugalInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Clinical Medicine–Neurosurgery, University of Eastern Finland, 70210 Kuopio, FinlandResearch Institute, Shiga Medical Center, Shiga 524-8524, JapanDepartment of Pharmacology, Department of Integrative and Systems Physiology, Department of Cell Systems and Anatomy, Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX 77030, USADepartment of Pharmacology, Department of Integrative and Systems Physiology, Department of Cell Systems and Anatomy, Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX 77030, USAInstitute of Clinical Medicine–Neurology, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandA.I Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210 Kuopio, FinlandInstitute of Biomedicine, University of Eastern Finland, 70210 Kuopio, FinlandAlzheimer’s disease (AD) is a neurodegenerative disease characterized by aberrant amyloid-β (Aβ) and hyperphosphorylated tau aggregation. We have previously investigated the involvement of SEPTIN family members in AD-related cellular processes and discovered a role for SEPTIN8 in the sorting and accumulation of β-secretase. Here, we elucidated the potential role of SEPTIN5, an interaction partner of SEPTIN8, in the cellular processes relevant for AD, including amyloid precursor protein (APP) processing and the generation of Aβ. The in vitro and in vivo studies both revealed that the downregulation of SEPTIN5 reduced the levels of APP C-terminal fragments (APP CTFs) and Aβ in neuronal cells and in the cortex of Septin5 knockout mice. Mechanistic elucidation revealed that the downregulation of SEPTIN5 increased the degradation of APP CTFs, without affecting the secretory pathway-related trafficking or the endocytosis of APP. Furthermore, we found that the APP CTFs were degraded, to a large extent, via the autophagosomal pathway and that the downregulation of SEPTIN5 enhanced autophagosomal activity in neuronal cells as indicated by altered levels of key autophagosomal markers. Collectively, our data suggest that the downregulation of SEPTIN5 increases the autophagy-mediated degradation of APP CTFs, leading to reduced levels of Aβ in neuronal cells.https://www.mdpi.com/2073-4409/9/11/2482AβAlzheimer’s diseaseAPP C-terminal fragmentsautophagySEPTIN5
spellingShingle Mikael Marttinen
Catarina B. Ferreira
Kaisa M. A. Paldanius
Mari Takalo
Teemu Natunen
Petra Mäkinen
Luukas Leppänen
Ville Leinonen
Kenji Tanigaki
Gina Kang
Noboru Hiroi
Hilkka Soininen
Kirsi Rilla
Annakaisa Haapasalo
Mikko Hiltunen
Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ
Cells

Alzheimer’s disease
APP C-terminal fragments
autophagy
SEPTIN5
title Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ
title_full Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ
title_fullStr Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ
title_full_unstemmed Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ
title_short Presynaptic Vesicle Protein SEPTIN5 Regulates the Degradation of APP C-Terminal Fragments and the Levels of Aβ
title_sort presynaptic vesicle protein septin5 regulates the degradation of app c terminal fragments and the levels of aβ
topic
Alzheimer’s disease
APP C-terminal fragments
autophagy
SEPTIN5
url https://www.mdpi.com/2073-4409/9/11/2482
work_keys_str_mv AT mikaelmarttinen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT catarinabferreira presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT kaisamapaldanius presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT maritakalo presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT teemunatunen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT petramakinen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT luukasleppanen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT villeleinonen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT kenjitanigaki presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT ginakang presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT noboruhiroi presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT hilkkasoininen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT kirsirilla presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT annakaisahaapasalo presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab
AT mikkohiltunen presynapticvesicleproteinseptin5regulatesthedegradationofappcterminalfragmentsandthelevelsofab